RiceBran Technologies
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RIBT research report →
Companywww.ricebrantech.com
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends.
- CEO
- Eric Tompkins
- IPO
- 2003
- Employees
- 35
- HQ
- Tomball, TX, US
Price Chart
Valuation
- Market Cap
- $1.00K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.65
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -1.81%
- Op Margin
- -28.06%
- Net Margin
- -39.63%
- ROE
- -181.15%
- ROIC
- -247.08%
Growth & Income
- Revenue
- $22.65M · -15.00%
- Net Income
- $-8,975,000 · -14.21%
- EPS
- $-1.28 · 9.86%
- Op Income
- $-6,355,000
- FCF YoY
- 30.94%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.24
- Avg Volume
- 559
Get TickerSpark's AI analysis on RIBT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 3, 24 | Russell Georgina | other | 0 |
| Jan 3, 24 | Rosenthal Brent David | other | 0 |
| Jan 3, 24 | Rosenthal Brent David | other | 4,816 |
| Jan 3, 24 | CHEMEROW DAVID I. | other | 0 |
| Jan 3, 24 | CHEMEROW DAVID I. | other | 0 |
| Jan 3, 24 | CHEMEROW DAVID I. | other | 4,817 |
| Jan 3, 24 | Tompkins Eric | other | 0 |
| Jan 3, 24 | Tompkins Eric | other | 2,853 |
| Jan 3, 24 | Tompkins Eric | other | 1,422 |
| Jan 3, 24 | Flynn James P | other | 0 |
Our RIBT Coverage
We haven't published any research on RIBT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RIBT Report →